| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 53 | 2024 | 256 | 12.470 |
Why?
|
| Apolipoprotein A-I | 31 | 2017 | 63 | 5.540 |
Why?
|
| Apolipoproteins E | 57 | 2018 | 136 | 5.510 |
Why?
|
| Lipoproteins | 37 | 2022 | 137 | 4.150 |
Why?
|
| Lipoproteins, HDL | 34 | 2016 | 91 | 3.640 |
Why?
|
| Receptors, LDL | 23 | 2019 | 54 | 2.810 |
Why?
|
| Cholesterol | 37 | 2019 | 364 | 2.460 |
Why?
|
| Arteriosclerosis | 26 | 2004 | 106 | 2.430 |
Why?
|
| Disease Models, Animal | 21 | 2024 | 2495 | 1.780 |
Why?
|
| Lipid Metabolism | 22 | 2019 | 214 | 1.770 |
Why?
|
| Peptides | 10 | 2013 | 656 | 1.750 |
Why?
|
| Animals | 179 | 2024 | 28155 | 1.730 |
Why?
|
| Natural Killer T-Cells | 5 | 2019 | 46 | 1.650 |
Why?
|
| Arteries | 9 | 2024 | 171 | 1.580 |
Why?
|
| Serum Amyloid A Protein | 9 | 2016 | 25 | 1.520 |
Why?
|
| Macrophages | 24 | 2018 | 610 | 1.510 |
Why?
|
| Saccharomyces cerevisiae | 32 | 2004 | 460 | 1.480 |
Why?
|
| Mice | 74 | 2024 | 12269 | 1.350 |
Why?
|
| Cholesterol, HDL | 13 | 2019 | 173 | 1.340 |
Why?
|
| Hypercholesterolemia | 7 | 2022 | 160 | 1.270 |
Why?
|
| Inflammation | 13 | 2022 | 1050 | 1.200 |
Why?
|
| Plaque, Atherosclerotic | 6 | 2022 | 58 | 1.190 |
Why?
|
| Lipoproteins, LDL | 21 | 2016 | 83 | 1.070 |
Why?
|
| Mitochondria | 28 | 2004 | 612 | 1.050 |
Why?
|
| Mice, Knockout | 28 | 2019 | 2121 | 0.950 |
Why?
|
| Liver | 39 | 2012 | 1210 | 0.920 |
Why?
|
| Hyperlipidemias | 7 | 2022 | 91 | 0.870 |
Why?
|
| Glycoproteins | 8 | 2012 | 220 | 0.830 |
Why?
|
| Antigens, CD1d | 3 | 2019 | 32 | 0.820 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2011 | 140 | 0.720 |
Why?
|
| Apolipoproteins | 11 | 2010 | 34 | 0.710 |
Why?
|
| Dietary Fats | 15 | 2011 | 135 | 0.710 |
Why?
|
| Biomimetic Materials | 2 | 2014 | 25 | 0.710 |
Why?
|
| Acute-Phase Reaction | 5 | 2003 | 16 | 0.710 |
Why?
|
| Immune System | 4 | 2007 | 101 | 0.690 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2014 | 353 | 0.680 |
Why?
|
| Immunity, Innate | 5 | 2017 | 463 | 0.650 |
Why?
|
| Inbreeding | 2 | 2017 | 48 | 0.630 |
Why?
|
| Triglycerides | 23 | 2014 | 231 | 0.620 |
Why?
|
| Aortic Diseases | 4 | 2018 | 87 | 0.610 |
Why?
|
| Humans | 97 | 2024 | 93515 | 0.610 |
Why?
|
| Mice, Inbred C57BL | 27 | 2019 | 3435 | 0.610 |
Why?
|
| Aorta | 17 | 2019 | 273 | 0.590 |
Why?
|
| Lipoproteins, VLDL | 20 | 2008 | 37 | 0.570 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2004 | 299 | 0.560 |
Why?
|
| Coronary Artery Disease | 3 | 2016 | 375 | 0.560 |
Why?
|
| Lipids | 24 | 2017 | 278 | 0.520 |
Why?
|
| Aryldialkylphosphatase | 3 | 2010 | 5 | 0.490 |
Why?
|
| Carrier Proteins | 4 | 2018 | 663 | 0.490 |
Why?
|
| Cardiovascular Diseases | 5 | 2019 | 754 | 0.480 |
Why?
|
| Hemodynamics | 3 | 2024 | 713 | 0.460 |
Why?
|
| Amyloid beta-Peptides | 10 | 2011 | 245 | 0.450 |
Why?
|
| Killer Cells, Natural | 3 | 2007 | 286 | 0.450 |
Why?
|
| Molecular Mimicry | 3 | 2010 | 17 | 0.430 |
Why?
|
| DNA, Mitochondrial | 13 | 1990 | 200 | 0.430 |
Why?
|
| Genes, Fungal | 9 | 1999 | 62 | 0.430 |
Why?
|
| Hyperlipoproteinemia Type II | 2 | 2014 | 23 | 0.430 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 148 | 0.420 |
Why?
|
| Plants, Genetically Modified | 1 | 2014 | 41 | 0.420 |
Why?
|
| Proprotein Convertases | 1 | 2014 | 27 | 0.420 |
Why?
|
| Peroxidase | 1 | 2014 | 54 | 0.420 |
Why?
|
| Cholesterol, VLDL | 4 | 2008 | 14 | 0.410 |
Why?
|
| Lysophospholipids | 1 | 2014 | 67 | 0.410 |
Why?
|
| Alzheimer Disease | 6 | 2012 | 603 | 0.410 |
Why?
|
| Transcription, Genetic | 16 | 2003 | 1117 | 0.400 |
Why?
|
| Protein Binding | 11 | 2018 | 1534 | 0.390 |
Why?
|
| Diet, Atherogenic | 4 | 2008 | 13 | 0.390 |
Why?
|
| Biological Transport | 9 | 2016 | 404 | 0.380 |
Why?
|
| Fungal Proteins | 4 | 1999 | 145 | 0.380 |
Why?
|
| Promoter Regions, Genetic | 7 | 1998 | 962 | 0.380 |
Why?
|
| Antibodies | 3 | 2011 | 348 | 0.380 |
Why?
|
| Lipoproteins, HDL3 | 4 | 2008 | 8 | 0.370 |
Why?
|
| Kinetics | 26 | 2010 | 1492 | 0.370 |
Why?
|
| Nanoparticles | 1 | 2014 | 198 | 0.370 |
Why?
|
| Transcription Factors | 5 | 2004 | 1691 | 0.360 |
Why?
|
| Amino Acid Sequence | 13 | 2010 | 2012 | 0.360 |
Why?
|
| Brachiocephalic Trunk | 5 | 2013 | 14 | 0.360 |
Why?
|
| Protein Structure, Secondary | 8 | 2010 | 337 | 0.350 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 16 | 2011 | 251 | 0.350 |
Why?
|
| Foam Cells | 5 | 2016 | 17 | 0.350 |
Why?
|
| Epitopes | 4 | 2016 | 254 | 0.350 |
Why?
|
| Molecular Sequence Data | 15 | 2010 | 2910 | 0.350 |
Why?
|
| Protein Transport | 4 | 2010 | 438 | 0.350 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 590 | 0.350 |
Why?
|
| Fatty Acids, Unsaturated | 3 | 2005 | 27 | 0.340 |
Why?
|
| Benzamides | 1 | 2012 | 246 | 0.340 |
Why?
|
| Obesity | 6 | 2018 | 1018 | 0.340 |
Why?
|
| Polymorphism, Genetic | 4 | 2012 | 826 | 0.340 |
Why?
|
| Male | 69 | 2019 | 44557 | 0.330 |
Why?
|
| Rats | 45 | 2011 | 4072 | 0.330 |
Why?
|
| Astrocytes | 5 | 2011 | 141 | 0.320 |
Why?
|
| Signal Transduction | 7 | 2018 | 3502 | 0.310 |
Why?
|
| Lipoproteins, HDL2 | 2 | 2008 | 5 | 0.310 |
Why?
|
| Proline | 2 | 2009 | 49 | 0.300 |
Why?
|
| Hypertriglyceridemia | 5 | 2013 | 72 | 0.290 |
Why?
|
| Metabolic Syndrome | 1 | 2010 | 122 | 0.290 |
Why?
|
| ATP Binding Cassette Transporter 1 | 3 | 2015 | 8 | 0.290 |
Why?
|
| RNA, Messenger | 17 | 2013 | 2026 | 0.280 |
Why?
|
| Ceramides | 1 | 2008 | 36 | 0.280 |
Why?
|
| Aging | 4 | 2012 | 727 | 0.280 |
Why?
|
| Hypolipidemic Agents | 2 | 2019 | 96 | 0.270 |
Why?
|
| DNA-Binding Proteins | 9 | 2008 | 1234 | 0.270 |
Why?
|
| Female | 40 | 2019 | 48702 | 0.270 |
Why?
|
| RNA | 8 | 1999 | 573 | 0.270 |
Why?
|
| Phospholipids | 18 | 2004 | 108 | 0.270 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2007 | 27 | 0.270 |
Why?
|
| Trypsin | 5 | 2016 | 94 | 0.270 |
Why?
|
| Insulin | 6 | 2010 | 1185 | 0.260 |
Why?
|
| Cognition | 1 | 2012 | 627 | 0.260 |
Why?
|
| Adenoviridae | 4 | 2011 | 340 | 0.260 |
Why?
|
| Inflammation Mediators | 1 | 2008 | 159 | 0.260 |
Why?
|
| Species Specificity | 9 | 2013 | 684 | 0.250 |
Why?
|
| Lipolysis | 3 | 1998 | 24 | 0.250 |
Why?
|
| Mitochondrial Proteins | 3 | 2004 | 128 | 0.250 |
Why?
|
| Translocation, Genetic | 2 | 2004 | 248 | 0.250 |
Why?
|
| Blood Vessels | 3 | 2019 | 91 | 0.250 |
Why?
|
| Adoptive Transfer | 1 | 2007 | 172 | 0.250 |
Why?
|
| Insulin-Secreting Cells | 1 | 2010 | 441 | 0.250 |
Why?
|
| Nitric Oxide | 2 | 2018 | 281 | 0.240 |
Why?
|
| Arginine | 2 | 2006 | 141 | 0.240 |
Why?
|
| Arginase | 1 | 2006 | 15 | 0.240 |
Why?
|
| Fatty Acids | 7 | 2007 | 145 | 0.240 |
Why?
|
| Phenotype | 9 | 2016 | 2544 | 0.240 |
Why?
|
| Lymphotoxin beta Receptor | 3 | 2013 | 25 | 0.230 |
Why?
|
| Diet | 5 | 2018 | 460 | 0.230 |
Why?
|
| Homeostasis | 4 | 2015 | 460 | 0.230 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2007 | 319 | 0.230 |
Why?
|
| Protein Sorting Signals | 2 | 2004 | 42 | 0.230 |
Why?
|
| Apolipoproteins B | 11 | 2004 | 36 | 0.230 |
Why?
|
| Mutation | 20 | 2014 | 4272 | 0.220 |
Why?
|
| Cell Line | 12 | 2015 | 2464 | 0.220 |
Why?
|
| Cardiomyopathies | 1 | 2008 | 291 | 0.220 |
Why?
|
| Cells, Cultured | 19 | 2018 | 2850 | 0.220 |
Why?
|
| Adipose Tissue | 5 | 2018 | 270 | 0.220 |
Why?
|
| Adaptive Immunity | 2 | 2019 | 179 | 0.220 |
Why?
|
| Immunocompromised Host | 2 | 2005 | 137 | 0.210 |
Why?
|
| Peptide Fragments | 4 | 2002 | 470 | 0.210 |
Why?
|
| Temperature | 9 | 2004 | 424 | 0.210 |
Why?
|
| Microscopy, Electron | 12 | 2008 | 439 | 0.210 |
Why?
|
| Granulosa Cells | 3 | 1989 | 31 | 0.210 |
Why?
|
| Hemorheology | 1 | 2003 | 8 | 0.200 |
Why?
|
| RNA, Fungal | 4 | 1995 | 43 | 0.200 |
Why?
|
| Disease Progression | 5 | 2018 | 1531 | 0.200 |
Why?
|
| Immunity | 1 | 2004 | 153 | 0.200 |
Why?
|
| Gene Expression Regulation | 8 | 2016 | 1985 | 0.200 |
Why?
|
| Cholesterol, Dietary | 10 | 2007 | 26 | 0.200 |
Why?
|
| Orphan Nuclear Receptors | 4 | 2011 | 15 | 0.200 |
Why?
|
| Golgi Apparatus | 3 | 1993 | 115 | 0.200 |
Why?
|
| Autoantibodies | 1 | 2004 | 277 | 0.190 |
Why?
|
| Molecular Chaperones | 2 | 2000 | 125 | 0.190 |
Why?
|
| Cholesterol, LDL | 6 | 2010 | 246 | 0.190 |
Why?
|
| Diet, High-Fat | 4 | 2016 | 135 | 0.190 |
Why?
|
| Base Sequence | 16 | 2014 | 2220 | 0.180 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 1587 | 0.180 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 215 | 0.180 |
Why?
|
| Hypertension | 1 | 2007 | 757 | 0.180 |
Why?
|
| Dexamethasone | 2 | 2014 | 312 | 0.180 |
Why?
|
| Oxidative Stress | 3 | 2015 | 467 | 0.180 |
Why?
|
| RNA, Ribosomal | 4 | 1999 | 65 | 0.180 |
Why?
|
| RNA, Transfer | 8 | 1987 | 168 | 0.170 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 436 | 0.170 |
Why?
|
| Rabbits | 7 | 2004 | 618 | 0.170 |
Why?
|
| Immunization | 2 | 2014 | 154 | 0.170 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 2 | 2013 | 14 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2014 | 337 | 0.160 |
Why?
|
| Swine | 1 | 2022 | 588 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2020 | 477 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2016 | 2465 | 0.160 |
Why?
|
| Hydroxysteroids | 2 | 2011 | 10 | 0.160 |
Why?
|
| Cell Biology | 1 | 2020 | 15 | 0.160 |
Why?
|
| Rutamycin | 3 | 1990 | 4 | 0.150 |
Why?
|
| Lymphocytes | 5 | 2016 | 454 | 0.150 |
Why?
|
| Organ Specificity | 4 | 2013 | 279 | 0.150 |
Why?
|
| Transfection | 5 | 2003 | 880 | 0.150 |
Why?
|
| Ribosomal Proteins | 1 | 1999 | 43 | 0.150 |
Why?
|
| Amino Acid Substitution | 2 | 2000 | 331 | 0.150 |
Why?
|
| Macrophages, Peritoneal | 2 | 2016 | 25 | 0.150 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2016 | 232 | 0.150 |
Why?
|
| Reye Syndrome | 2 | 1991 | 16 | 0.150 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 1990 | 98 | 0.140 |
Why?
|
| Heparin | 6 | 1994 | 181 | 0.140 |
Why?
|
| Hyperlipoproteinemias | 2 | 2016 | 7 | 0.140 |
Why?
|
| Mitochondria, Liver | 9 | 1985 | 29 | 0.140 |
Why?
|
| Papio | 10 | 1996 | 87 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2003 | 555 | 0.140 |
Why?
|
| Biological Mimicry | 1 | 2018 | 18 | 0.140 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 86 | 0.140 |
Why?
|
| Cardiology | 1 | 2019 | 120 | 0.140 |
Why?
|
| Poly T | 1 | 1998 | 2 | 0.140 |
Why?
|
| Gemfibrozil | 1 | 1998 | 8 | 0.140 |
Why?
|
| Mesenteric Arteries | 1 | 2018 | 29 | 0.140 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 17 | 0.140 |
Why?
|
| Cell Fractionation | 6 | 2003 | 66 | 0.140 |
Why?
|
| Vasodilation | 1 | 2018 | 91 | 0.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2008 | 123 | 0.130 |
Why?
|
| Hematopoiesis | 1 | 2018 | 183 | 0.130 |
Why?
|
| Protein Structure, Tertiary | 5 | 2008 | 729 | 0.130 |
Why?
|
| Rats, Inbred Strains | 11 | 1991 | 304 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2016 | 134 | 0.130 |
Why?
|
| Lysosomes | 3 | 1991 | 123 | 0.130 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2018 | 121 | 0.130 |
Why?
|
| Clusterin | 3 | 2010 | 13 | 0.130 |
Why?
|
| Glucose | 8 | 2010 | 692 | 0.130 |
Why?
|
| Metabolic Clearance Rate | 2 | 2009 | 117 | 0.130 |
Why?
|
| Apolipoprotein E3 | 6 | 2006 | 7 | 0.130 |
Why?
|
| Antigens | 2 | 2016 | 224 | 0.130 |
Why?
|
| Oxygen Consumption | 7 | 1995 | 238 | 0.120 |
Why?
|
| Immunocompetence | 2 | 2008 | 24 | 0.120 |
Why?
|
| B-Lymphocytes | 4 | 2016 | 701 | 0.120 |
Why?
|
| Pinocytosis | 1 | 2016 | 6 | 0.120 |
Why?
|
| Scavenger Receptors, Class E | 1 | 2016 | 3 | 0.120 |
Why?
|
| Sterol Esterase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 319 | 0.120 |
Why?
|
| HMGB1 Protein | 1 | 2016 | 18 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 28 | 0.120 |
Why?
|
| Operon | 2 | 1986 | 34 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 1999 | 443 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 1395 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2014 | 454 | 0.120 |
Why?
|
| Membrane Potentials | 3 | 2004 | 405 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 887 | 0.120 |
Why?
|
| Diet, Western | 1 | 2016 | 45 | 0.120 |
Why?
|
| Structure-Activity Relationship | 2 | 2014 | 422 | 0.120 |
Why?
|
| Chromatography, Gel | 5 | 2011 | 100 | 0.120 |
Why?
|
| Lipid Peroxidation | 1 | 2015 | 45 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2019 | 621 | 0.120 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 3 | 2006 | 3 | 0.120 |
Why?
|
| Intracellular Membranes | 3 | 1995 | 112 | 0.110 |
Why?
|
| Protein Biosynthesis | 9 | 1992 | 376 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2005 | 274 | 0.110 |
Why?
|
| T-Lymphocytes | 5 | 2013 | 1275 | 0.110 |
Why?
|
| Chaperonin 60 | 1 | 1995 | 7 | 0.110 |
Why?
|
| Cytoplasm | 7 | 1991 | 278 | 0.110 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 740 | 0.110 |
Why?
|
| Guinea Pigs | 3 | 1990 | 163 | 0.110 |
Why?
|
| Alginates | 1 | 2014 | 16 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2019 | 438 | 0.110 |
Why?
|
| In Vitro Techniques | 11 | 1996 | 948 | 0.110 |
Why?
|
| Peptidomimetics | 1 | 2014 | 3 | 0.110 |
Why?
|
| Protein Precursors | 1 | 1995 | 135 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2016 | 189 | 0.110 |
Why?
|
| Pulmonary Blastoma | 1 | 2014 | 5 | 0.110 |
Why?
|
| Lipase | 3 | 2013 | 21 | 0.110 |
Why?
|
| Body Weight | 3 | 2018 | 449 | 0.110 |
Why?
|
| Ribonuclease III | 1 | 2014 | 17 | 0.110 |
Why?
|
| Gene Expression Profiling | 4 | 2014 | 1518 | 0.110 |
Why?
|
| Recombinant Proteins | 5 | 2011 | 988 | 0.100 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2014 | 36 | 0.100 |
Why?
|
| Proprotein Convertase 9 | 1 | 2014 | 28 | 0.100 |
Why?
|
| Dicarboxylic Acids | 2 | 1991 | 24 | 0.100 |
Why?
|
| Aspirin | 2 | 1993 | 167 | 0.100 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 2 | 2012 | 6 | 0.100 |
Why?
|
| Weight Gain | 1 | 2014 | 128 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 72 | 0.100 |
Why?
|
| Hepatocytes | 2 | 2013 | 129 | 0.100 |
Why?
|
| Cell Compartmentation | 2 | 1993 | 69 | 0.100 |
Why?
|
| Macaca mulatta | 12 | 2003 | 448 | 0.100 |
Why?
|
| Chromosome Deletion | 4 | 1988 | 214 | 0.100 |
Why?
|
| Leupeptins | 1 | 1993 | 21 | 0.100 |
Why?
|
| Sequence Deletion | 2 | 2004 | 209 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 674 | 0.100 |
Why?
|
| Genes | 5 | 1988 | 258 | 0.100 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1993 | 52 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 2014 | 173 | 0.100 |
Why?
|
| Calcium | 3 | 2016 | 1176 | 0.100 |
Why?
|
| Up-Regulation | 3 | 2012 | 730 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2013 | 524 | 0.100 |
Why?
|
| Diabetic Angiopathies | 1 | 1993 | 37 | 0.100 |
Why?
|
| Intestinal Absorption | 1 | 2013 | 125 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 1 | 1993 | 88 | 0.100 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2012 | 23 | 0.100 |
Why?
|
| Adenosine Triphosphatases | 4 | 1990 | 141 | 0.100 |
Why?
|
| Apolipoprotein A-II | 2 | 2010 | 3 | 0.100 |
Why?
|
| Remission Induction | 1 | 2015 | 738 | 0.090 |
Why?
|
| Endopeptidases | 1 | 1993 | 116 | 0.090 |
Why?
|
| Antioxidants | 1 | 2014 | 231 | 0.090 |
Why?
|
| Spleen | 3 | 2010 | 374 | 0.090 |
Why?
|
| Risk Factors | 4 | 2008 | 5899 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1989 | 122 | 0.090 |
Why?
|
| Intestine, Small | 1 | 2014 | 310 | 0.090 |
Why?
|
| Chylomicrons | 6 | 1990 | 12 | 0.090 |
Why?
|
| Biochemistry | 1 | 2012 | 29 | 0.090 |
Why?
|
| Carbohydrate Metabolism | 1 | 2011 | 31 | 0.090 |
Why?
|
| Choline | 1 | 2011 | 24 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2012 | 163 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 1993 | 170 | 0.090 |
Why?
|
| Cytokines | 2 | 2007 | 863 | 0.090 |
Why?
|
| Renin-Angiotensin System | 1 | 2012 | 84 | 0.090 |
Why?
|
| Oxidation-Reduction | 5 | 2004 | 410 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 216 | 0.090 |
Why?
|
| Cholesterol Esters | 8 | 1994 | 12 | 0.090 |
Why?
|
| Plant Oils | 2 | 1994 | 8 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2012 | 187 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 131 | 0.090 |
Why?
|
| Apolipoproteins A | 4 | 2003 | 10 | 0.080 |
Why?
|
| Receptors, Lipoprotein | 2 | 2001 | 4 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 1914 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 1028 | 0.080 |
Why?
|
| Oligomycins | 1 | 1990 | 5 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2012 | 314 | 0.080 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2010 | 4 | 0.080 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 287 | 0.080 |
Why?
|
| Triticum | 3 | 2004 | 24 | 0.080 |
Why?
|
| Time Factors | 10 | 2015 | 5410 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2002 | 384 | 0.080 |
Why?
|
| Cyclic AMP | 2 | 1989 | 276 | 0.080 |
Why?
|
| KATP Channels | 1 | 2010 | 18 | 0.080 |
Why?
|
| Apolipoprotein E4 | 4 | 2006 | 32 | 0.080 |
Why?
|
| Eating | 4 | 1992 | 162 | 0.080 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 1990 | 66 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 657 | 0.080 |
Why?
|
| Nucleic Acid Conformation | 4 | 2014 | 342 | 0.080 |
Why?
|
| Immunoglobulin M | 1 | 2010 | 153 | 0.080 |
Why?
|
| Brain | 3 | 2000 | 2391 | 0.080 |
Why?
|
| Organ Size | 2 | 2010 | 362 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2003 | 220 | 0.080 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 195 | 0.080 |
Why?
|
| Lovastatin | 1 | 1989 | 28 | 0.080 |
Why?
|
| Monocytes | 3 | 2016 | 215 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2001 | 404 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 3 | 2016 | 281 | 0.080 |
Why?
|
| Liver X Receptors | 4 | 2011 | 15 | 0.080 |
Why?
|
| Endopeptidase K | 2 | 2002 | 12 | 0.080 |
Why?
|
| Biomarkers | 1 | 2016 | 1910 | 0.080 |
Why?
|
| Cell-Free System | 3 | 2004 | 47 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2014 | 784 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 392 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 1338 | 0.070 |
Why?
|
| Autophagy | 1 | 1991 | 172 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2014 | 580 | 0.070 |
Why?
|
| Plasmids | 5 | 1988 | 273 | 0.070 |
Why?
|
| Biotinylation | 1 | 2009 | 42 | 0.070 |
Why?
|
| Saccharomyces | 5 | 1972 | 22 | 0.070 |
Why?
|
| Fish Oils | 1 | 1989 | 15 | 0.070 |
Why?
|
| Phorbol Esters | 1 | 1989 | 19 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2009 | 22 | 0.070 |
Why?
|
| Phosphorus Radioisotopes | 2 | 1987 | 21 | 0.070 |
Why?
|
| Aorta, Abdominal | 1 | 2009 | 58 | 0.070 |
Why?
|
| Isotope Labeling | 2 | 1987 | 52 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 464 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2009 | 191 | 0.070 |
Why?
|
| Sinus of Valsalva | 1 | 2008 | 16 | 0.070 |
Why?
|
| Myocardium | 3 | 2008 | 570 | 0.070 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2008 | 13 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2009 | 363 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2014 | 691 | 0.070 |
Why?
|
| Apolipoprotein B-100 | 2 | 2004 | 8 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 2 | 2012 | 174 | 0.070 |
Why?
|
| Potassium Deficiency | 4 | 1981 | 6 | 0.070 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2008 | 85 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 282 | 0.070 |
Why?
|
| Antifungal Agents | 2 | 1979 | 122 | 0.070 |
Why?
|
| Nutrition Assessment | 1 | 2007 | 21 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2012 | 990 | 0.070 |
Why?
|
| Fats, Unsaturated | 1 | 1987 | 1 | 0.070 |
Why?
|
| Ribonucleases | 3 | 2004 | 92 | 0.070 |
Why?
|
| Chicago | 1 | 2012 | 1464 | 0.070 |
Why?
|
| Mice, Knockout, ApoE | 2 | 2018 | 12 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 6 | 1986 | 194 | 0.060 |
Why?
|
| Intestinal Mucosa | 4 | 2013 | 824 | 0.060 |
Why?
|
| Particle Size | 2 | 1999 | 126 | 0.060 |
Why?
|
| Sodium Dodecyl Sulfate | 3 | 2002 | 24 | 0.060 |
Why?
|
| Kidney Medulla | 4 | 1981 | 77 | 0.060 |
Why?
|
| Life Style | 1 | 2007 | 183 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2008 | 333 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1986 | 29 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2007 | 282 | 0.060 |
Why?
|
| Proton-Translocating ATPases | 1 | 1986 | 24 | 0.060 |
Why?
|
| Endometrial Neoplasms | 1 | 2009 | 227 | 0.060 |
Why?
|
| Kidney | 7 | 1998 | 1111 | 0.060 |
Why?
|
| Fatty Liver | 3 | 2018 | 106 | 0.060 |
Why?
|
| Safflower Oil | 1 | 2005 | 7 | 0.060 |
Why?
|
| Health Promotion | 1 | 2007 | 170 | 0.060 |
Why?
|
| Animal Feed | 1 | 2005 | 22 | 0.060 |
Why?
|
| Sulfonamides | 1 | 2008 | 331 | 0.060 |
Why?
|
| Age Factors | 1 | 2010 | 1906 | 0.060 |
Why?
|
| Circular Dichroism | 2 | 2005 | 117 | 0.060 |
Why?
|
| Glycolipids | 1 | 2005 | 26 | 0.060 |
Why?
|
| Cell Division | 7 | 1990 | 693 | 0.060 |
Why?
|
| Lipid Droplets | 1 | 2005 | 21 | 0.060 |
Why?
|
| Molecular Weight | 6 | 1993 | 292 | 0.060 |
Why?
|
| Skin | 1 | 1989 | 578 | 0.060 |
Why?
|
| Escherichia coli | 7 | 2001 | 563 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2005 | 224 | 0.060 |
Why?
|
| Colloids | 1 | 2005 | 28 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2007 | 712 | 0.060 |
Why?
|
| Triptorelin Pamoate | 1 | 1985 | 8 | 0.060 |
Why?
|
| Phosphatidylcholines | 3 | 2003 | 49 | 0.060 |
Why?
|
| Yeasts | 1 | 1985 | 50 | 0.060 |
Why?
|
| Amyloid | 1 | 2005 | 104 | 0.060 |
Why?
|
| Socioeconomic Factors | 1 | 2007 | 624 | 0.060 |
Why?
|
| DNA | 11 | 1990 | 1265 | 0.060 |
Why?
|
| Reducing Agents | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cluster Analysis | 4 | 2009 | 391 | 0.050 |
Why?
|
| Reticulocytes | 1 | 2004 | 25 | 0.050 |
Why?
|
| Cations | 1 | 2004 | 29 | 0.050 |
Why?
|
| Models, Immunological | 1 | 2005 | 84 | 0.050 |
Why?
|
| Templates, Genetic | 3 | 1990 | 31 | 0.050 |
Why?
|
| Protein Denaturation | 2 | 2002 | 109 | 0.050 |
Why?
|
| Esterases | 1 | 2004 | 13 | 0.050 |
Why?
|
| Chelating Agents | 1 | 2004 | 68 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2007 | 960 | 0.050 |
Why?
|
| Cell Nucleus | 5 | 1995 | 603 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 68 | 0.050 |
Why?
|
| Models, Biological | 2 | 2003 | 1768 | 0.050 |
Why?
|
| Antibody Formation | 1 | 2004 | 169 | 0.050 |
Why?
|
| Metals | 1 | 2004 | 102 | 0.050 |
Why?
|
| Alleles | 2 | 1999 | 1139 | 0.050 |
Why?
|
| Culture Media, Conditioned | 4 | 2012 | 103 | 0.050 |
Why?
|
| Genome, Human | 1 | 2009 | 823 | 0.050 |
Why?
|
| Sucrose | 2 | 2014 | 64 | 0.050 |
Why?
|
| Cholic Acids | 1 | 2003 | 7 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2004 | 284 | 0.050 |
Why?
|
| Genetic Complementation Test | 3 | 1995 | 84 | 0.050 |
Why?
|
| Adipocytes | 2 | 2014 | 169 | 0.050 |
Why?
|
| Testosterone | 1 | 1985 | 259 | 0.050 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2003 | 39 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2003 | 60 | 0.050 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 160 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2014 | 2365 | 0.050 |
Why?
|
| Submitochondrial Particles | 2 | 1999 | 3 | 0.050 |
Why?
|
| CHO Cells | 2 | 1993 | 187 | 0.050 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2002 | 34 | 0.050 |
Why?
|
| Lysine | 2 | 2003 | 182 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2004 | 247 | 0.050 |
Why?
|
| Albumins | 2 | 1993 | 123 | 0.050 |
Why?
|
| Models, Animal | 1 | 2003 | 282 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 1995 | 244 | 0.050 |
Why?
|
| DNA Replication | 3 | 1988 | 168 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2002 | 319 | 0.050 |
Why?
|
| Acid Phosphatase | 2 | 1981 | 28 | 0.050 |
Why?
|
| Potassium | 2 | 1973 | 232 | 0.050 |
Why?
|
| Cricetinae | 2 | 1993 | 532 | 0.050 |
Why?
|
| Insulin Resistance | 2 | 2014 | 379 | 0.050 |
Why?
|
| Perfusion | 7 | 1988 | 260 | 0.040 |
Why?
|
| Genotype | 2 | 2015 | 1866 | 0.040 |
Why?
|
| Aorta, Thoracic | 2 | 2016 | 149 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 2001 | 89 | 0.040 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2002 | 89 | 0.040 |
Why?
|
| Muscle, Smooth | 4 | 1977 | 300 | 0.040 |
Why?
|
| Microsomes | 4 | 1984 | 32 | 0.040 |
Why?
|
| Encephalitis | 1 | 2001 | 47 | 0.040 |
Why?
|
| Neuroglia | 1 | 2001 | 81 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 1999 | 587 | 0.040 |
Why?
|
| Estradiol | 2 | 2000 | 247 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 7 | 1988 | 94 | 0.040 |
Why?
|
| Cysteine | 2 | 2002 | 145 | 0.040 |
Why?
|
| Plasminogen | 1 | 2000 | 46 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1981 | 272 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 367 | 0.040 |
Why?
|
| Atrophy | 1 | 2000 | 128 | 0.040 |
Why?
|
| Sex Factors | 1 | 2003 | 1105 | 0.040 |
Why?
|
| Dendritic Cells | 2 | 2016 | 536 | 0.040 |
Why?
|
| Apoproteins | 5 | 1988 | 22 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2000 | 36 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 290 | 0.040 |
Why?
|
| Antibodies, Fungal | 1 | 1999 | 6 | 0.040 |
Why?
|
| Macromolecular Substances | 3 | 2002 | 164 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2011 | 1245 | 0.040 |
Why?
|
| Immunosorbent Techniques | 1 | 1999 | 11 | 0.040 |
Why?
|
| Lipopolysaccharides | 2 | 1999 | 301 | 0.040 |
Why?
|
| Cholera Toxin | 2 | 1989 | 21 | 0.040 |
Why?
|
| Subcellular Fractions | 4 | 1993 | 88 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1992 | 108 | 0.040 |
Why?
|
| Tritium | 11 | 1974 | 116 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2001 | 422 | 0.040 |
Why?
|
| Intestines | 2 | 2013 | 432 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 423 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2001 | 914 | 0.040 |
Why?
|
| Cytochromes | 3 | 1993 | 58 | 0.040 |
Why?
|
| Neurons | 3 | 2003 | 1582 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2019 | 124 | 0.040 |
Why?
|
| Extrachromosomal Inheritance | 2 | 1978 | 4 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2000 | 288 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1998 | 23 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 1978 | 31 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1999 | 307 | 0.030 |
Why?
|
| Thymine Nucleotides | 1 | 1998 | 6 | 0.030 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 556 | 0.030 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1998 | 15 | 0.030 |
Why?
|
| Orotic Acid | 3 | 1973 | 5 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 1998 | 104 | 0.030 |
Why?
|
| Panniculitis | 1 | 2018 | 11 | 0.030 |
Why?
|
| Fasting | 3 | 1992 | 163 | 0.030 |
Why?
|
| Fibroblasts | 3 | 2006 | 756 | 0.030 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 1997 | 25 | 0.030 |
Why?
|
| Apolipoprotein E2 | 1 | 1997 | 3 | 0.030 |
Why?
|
| Bucladesine | 2 | 1989 | 12 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 2755 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1998 | 92 | 0.030 |
Why?
|
| Cell Movement | 3 | 2012 | 809 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 1998 | 86 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1987 | 76 | 0.030 |
Why?
|
| Neurites | 1 | 1997 | 36 | 0.030 |
Why?
|
| Vitamin A | 3 | 1992 | 27 | 0.030 |
Why?
|
| Adolescent | 4 | 2003 | 9606 | 0.030 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2003 | 826 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2003 | 1621 | 0.030 |
Why?
|
| Receptor for Advanced Glycation End Products | 1 | 2016 | 20 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2016 | 13 | 0.030 |
Why?
|
| DNA, Fungal | 2 | 1995 | 60 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 1546 | 0.030 |
Why?
|
| Edetic Acid | 2 | 1995 | 40 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 4 | 1992 | 67 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 149 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2016 | 118 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2016 | 119 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2018 | 299 | 0.030 |
Why?
|
| Tunica Intima | 2 | 2009 | 61 | 0.030 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1995 | 4 | 0.030 |
Why?
|
| Valinomycin | 1 | 1995 | 8 | 0.030 |
Why?
|
| Phenanthrolines | 1 | 1995 | 8 | 0.030 |
Why?
|
| Digitonin | 1 | 1995 | 10 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 280 | 0.030 |
Why?
|
| Sialic Acids | 1 | 1975 | 18 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 1995 | 30 | 0.030 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1975 | 12 | 0.030 |
Why?
|
| Food | 2 | 1994 | 92 | 0.030 |
Why?
|
| Hexuronic Acids | 1 | 2014 | 9 | 0.030 |
Why?
|
| Glucuronic Acid | 1 | 2014 | 10 | 0.030 |
Why?
|
| Isoleucine | 1 | 1995 | 18 | 0.030 |
Why?
|
| Ultracentrifugation | 4 | 2006 | 35 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 120 | 0.030 |
Why?
|
| Valine | 1 | 1995 | 46 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 1977 | 361 | 0.030 |
Why?
|
| Drug Resistance | 2 | 1990 | 233 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2014 | 35 | 0.030 |
Why?
|
| Alanine | 1 | 1995 | 83 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 39 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 409 | 0.030 |
Why?
|
| Chromatography, Affinity | 2 | 1988 | 83 | 0.030 |
Why?
|
| Cathepsins | 2 | 1993 | 22 | 0.030 |
Why?
|
| Coconut Oil | 2 | 1994 | 4 | 0.030 |
Why?
|
| Corn Oil | 2 | 1994 | 3 | 0.030 |
Why?
|
| Exons | 1 | 1996 | 450 | 0.030 |
Why?
|
| Coronary Disease | 3 | 1990 | 223 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 76 | 0.030 |
Why?
|
| Genetic Linkage | 2 | 1986 | 613 | 0.030 |
Why?
|
| Point Mutation | 1 | 1995 | 238 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2014 | 113 | 0.030 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 80 | 0.030 |
Why?
|
| Apolipoproteins C | 1 | 1993 | 5 | 0.030 |
Why?
|
| Proteomics | 1 | 2015 | 264 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1994 | 493 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2013 | 49 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2014 | 1799 | 0.020 |
Why?
|
| Exome | 1 | 2014 | 141 | 0.020 |
Why?
|
| Brefeldin A | 1 | 1993 | 10 | 0.020 |
Why?
|
| Cathepsin L | 1 | 1993 | 7 | 0.020 |
Why?
|
| Ammonium Chloride | 1 | 1993 | 22 | 0.020 |
Why?
|
| Cathepsin B | 1 | 1993 | 11 | 0.020 |
Why?
|
| Chloroquine | 1 | 1993 | 13 | 0.020 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 73 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 502 | 0.020 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 28 | 0.020 |
Why?
|
| Cyclopentanes | 1 | 1993 | 27 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 543 | 0.020 |
Why?
|
| Adiposity | 1 | 2013 | 76 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 192 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2013 | 13 | 0.020 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2014 | 162 | 0.020 |
Why?
|
| CD11 Antigens | 1 | 2012 | 14 | 0.020 |
Why?
|
| Dactinomycin | 1 | 1992 | 32 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2012 | 42 | 0.020 |
Why?
|
| CD40 Antigens | 1 | 2012 | 43 | 0.020 |
Why?
|
| Sterol O-Acyltransferase | 2 | 1994 | 10 | 0.020 |
Why?
|
| Lipoprotein Lipase | 3 | 1988 | 14 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 84 | 0.020 |
Why?
|
| Fumarates | 1 | 2012 | 20 | 0.020 |
Why?
|
| Amides | 1 | 2012 | 54 | 0.020 |
Why?
|
| Forecasting | 2 | 1991 | 293 | 0.020 |
Why?
|
| Renin | 1 | 2012 | 67 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1993 | 135 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2012 | 171 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 603 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 1996 | 578 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 2 | 1971 | 31 | 0.020 |
Why?
|
| Adult | 7 | 2003 | 27918 | 0.020 |
Why?
|
| Immunoglobulin Fragments | 1 | 2011 | 23 | 0.020 |
Why?
|
| DNA, Single-Stranded | 2 | 1987 | 95 | 0.020 |
Why?
|
| Membrane Fluidity | 1 | 1991 | 9 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 292 | 0.020 |
Why?
|
| Body Mass Index | 1 | 1994 | 811 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 264 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 1990 | 13 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 893 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1990 | 68 | 0.020 |
Why?
|
| Rotenone | 1 | 1990 | 17 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 309 | 0.020 |
Why?
|
| NADH Dehydrogenase | 1 | 1990 | 22 | 0.020 |
Why?
|
| Hydrolysis | 2 | 1988 | 141 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2005 | 1353 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 1101 | 0.020 |
Why?
|
| Culture Media | 5 | 1995 | 139 | 0.020 |
Why?
|
| Thrombosis | 1 | 1993 | 309 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 261 | 0.020 |
Why?
|
| Aminoglutethimide | 1 | 1989 | 2 | 0.020 |
Why?
|
| Radioimmunoassay | 2 | 1980 | 144 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2012 | 375 | 0.020 |
Why?
|
| Hot Temperature | 4 | 1982 | 218 | 0.020 |
Why?
|
| Chloramphenicol | 4 | 1978 | 13 | 0.020 |
Why?
|
| Stathmin | 1 | 2009 | 3 | 0.020 |
Why?
|
| Tunica Media | 1 | 2009 | 16 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2009 | 15 | 0.020 |
Why?
|
| Chemokine CXCL13 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Colforsin | 1 | 1989 | 69 | 0.020 |
Why?
|
| Nucleotides | 1 | 1969 | 93 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2009 | 84 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1989 | 66 | 0.020 |
Why?
|
| Chromatography, Gas | 2 | 1987 | 27 | 0.020 |
Why?
|
| Esterification | 1 | 1988 | 7 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2009 | 54 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2009 | 76 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1988 | 31 | 0.020 |
Why?
|
| Organogenesis | 1 | 2009 | 50 | 0.020 |
Why?
|
| Electron Transport Complex IV | 5 | 1981 | 46 | 0.020 |
Why?
|
| Cholesterol Ester Transfer Proteins | 3 | 1994 | 34 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 309 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2009 | 211 | 0.020 |
Why?
|
| ras Proteins | 1 | 2009 | 132 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1988 | 59 | 0.020 |
Why?
|
| Adrenal Glands | 1 | 1968 | 74 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1987 | 5 | 0.020 |
Why?
|
| RNA, Transfer, Leu | 1 | 1987 | 11 | 0.020 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1987 | 14 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1968 | 120 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 208 | 0.020 |
Why?
|
| Reference Values | 1 | 1989 | 608 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1989 | 210 | 0.020 |
Why?
|
| Hydroxycholesterols | 1 | 1987 | 6 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 178 | 0.020 |
Why?
|
| Peritoneal Cavity | 1 | 1987 | 19 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1264 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1987 | 81 | 0.020 |
Why?
|
| Autoradiography | 1 | 1987 | 53 | 0.020 |
Why?
|
| Apolipoprotein B-48 | 1 | 1987 | 1 | 0.020 |
Why?
|
| Lymphotoxin-alpha | 1 | 2007 | 41 | 0.020 |
Why?
|
| Mathematics | 1 | 1987 | 180 | 0.020 |
Why?
|
| Neuroprotective Agents | 2 | 1998 | 98 | 0.020 |
Why?
|
| Deoxyribonuclease HindIII | 1 | 1986 | 4 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1986 | 28 | 0.020 |
Why?
|
| Centrifugation, Zonal | 2 | 1979 | 5 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 1986 | 17 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1986 | 60 | 0.010 |
Why?
|
| Immunodiffusion | 2 | 1979 | 27 | 0.010 |
Why?
|
| Congo Red | 1 | 2005 | 5 | 0.010 |
Why?
|
| Dyslipidemias | 1 | 2007 | 108 | 0.010 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2005 | 29 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1991 | 589 | 0.010 |
Why?
|
| Benzothiazoles | 1 | 2005 | 17 | 0.010 |
Why?
|
| Chinchilla | 1 | 1985 | 4 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 65 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1985 | 14 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 1524 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2006 | 137 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1985 | 49 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 666 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1985 | 135 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 1986 | 100 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 2005 | 131 | 0.010 |
Why?
|
| Infant | 2 | 1997 | 3220 | 0.010 |
Why?
|
| Plants | 1 | 1986 | 118 | 0.010 |
Why?
|
| Cell Count | 2 | 1997 | 197 | 0.010 |
Why?
|
| Cycloheximide | 3 | 2001 | 56 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1984 | 16 | 0.010 |
Why?
|
| Goats | 1 | 1984 | 17 | 0.010 |
Why?
|
| Thiazoles | 1 | 2005 | 124 | 0.010 |
Why?
|
| Microscopy, Atomic Force | 1 | 2005 | 53 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 82 | 0.010 |
Why?
|
| Uric Acid | 1 | 1985 | 137 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1997 | 3829 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1984 | 113 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2005 | 146 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1984 | 126 | 0.010 |
Why?
|
| Nucleic Acid Renaturation | 2 | 1974 | 5 | 0.010 |
Why?
|
| Methionine | 1 | 1984 | 64 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1986 | 123 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 476 | 0.010 |
Why?
|
| Blood Glucose | 4 | 1992 | 867 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1984 | 291 | 0.010 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 1984 | 7 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1985 | 99 | 0.010 |
Why?
|
| Phosphofructokinase-1 | 1 | 1984 | 4 | 0.010 |
Why?
|
| Membranes | 3 | 1975 | 35 | 0.010 |
Why?
|
| Glycoside Hydrolases | 1 | 1984 | 16 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 1984 | 57 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1984 | 47 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 2 | 1995 | 3 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 257 | 0.010 |
Why?
|
| Hippocampus | 2 | 1998 | 452 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 293 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 2003 | 88 | 0.010 |
Why?
|
| Cardiolipins | 2 | 1981 | 16 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2003 | 64 | 0.010 |
Why?
|
| Chromosome Aberrations | 2 | 2003 | 350 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2003 | 46 | 0.010 |
Why?
|
| Phosphorus | 1 | 2003 | 119 | 0.010 |
Why?
|
| Middle Aged | 4 | 1998 | 27573 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2003 | 106 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2003 | 273 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 3 | 1979 | 58 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2003 | 77 | 0.010 |
Why?
|
| Oxygen | 2 | 2003 | 769 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 634 | 0.010 |
Why?
|
| Phosphorus Isotopes | 3 | 1973 | 16 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1986 | 411 | 0.010 |
Why?
|
| Amino Acids | 3 | 1980 | 249 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1986 | 1052 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1991 | 1229 | 0.010 |
Why?
|
| Binding Sites | 2 | 2003 | 1133 | 0.010 |
Why?
|
| Salts | 1 | 2002 | 18 | 0.010 |
Why?
|
| Child | 3 | 1997 | 7355 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2003 | 166 | 0.010 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2001 | 11 | 0.010 |
Why?
|
| Diterpenes | 2 | 1992 | 24 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 147 | 0.010 |
Why?
|
| Neuraminidase | 1 | 1981 | 45 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 295 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 3 | 1970 | 16 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2001 | 35 | 0.010 |
Why?
|
| Glutamate Dehydrogenase | 2 | 1979 | 5 | 0.010 |
Why?
|
| Malate Dehydrogenase | 2 | 1979 | 9 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 2001 | 154 | 0.010 |
Why?
|
| Prognosis | 1 | 2009 | 3911 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 2 | 1975 | 260 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2002 | 114 | 0.010 |
Why?
|
| United States | 2 | 1993 | 7622 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 141 | 0.010 |
Why?
|
| Catheterization | 1 | 2002 | 218 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2000 | 71 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2001 | 352 | 0.010 |
Why?
|
| Galactose | 3 | 1975 | 31 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1660 | 0.010 |
Why?
|
| Nucleic Acid Denaturation | 3 | 1974 | 26 | 0.010 |
Why?
|
| Polysaccharides | 2 | 1971 | 96 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2000 | 140 | 0.010 |
Why?
|
| Transposases | 1 | 2000 | 24 | 0.010 |
Why?
|
| Centrifugation, Isopycnic | 1 | 1979 | 4 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 1980 | 45 | 0.010 |
Why?
|
| Pyruvate Decarboxylase | 1 | 1979 | 1 | 0.010 |
Why?
|
| Cytochrome Reductases | 1 | 1979 | 5 | 0.010 |
Why?
|
| Polyribosomes | 1 | 1979 | 20 | 0.010 |
Why?
|
| Basement Membrane | 2 | 1969 | 57 | 0.010 |
Why?
|
| Cytidine Diphosphate Diglycerides | 1 | 1978 | 1 | 0.010 |
Why?
|
| Deoxycytosine Nucleotides | 1 | 1978 | 1 | 0.010 |
Why?
|
| Phosphatidic Acids | 1 | 1978 | 4 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1969 | 308 | 0.010 |
Why?
|
| Cell Survival | 2 | 1998 | 1004 | 0.010 |
Why?
|
| Cell Fusion | 1 | 1978 | 34 | 0.010 |
Why?
|
| Spectrophotometry | 2 | 1975 | 103 | 0.010 |
Why?
|
| Serum | 1 | 1957 | 25 | 0.010 |
Why?
|
| DNA, Circular | 2 | 1974 | 11 | 0.010 |
Why?
|
| Isomerism | 1 | 1997 | 28 | 0.010 |
Why?
|
| Acriflavine | 1 | 1977 | 1 | 0.010 |
Why?
|
| Muscle Proteins | 1 | 1998 | 129 | 0.010 |
Why?
|
| Cell Death | 1 | 1998 | 253 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 1980 | 797 | 0.010 |
Why?
|
| Diploidy | 2 | 1973 | 34 | 0.010 |
Why?
|
| Haplorhini | 3 | 1975 | 77 | 0.010 |
Why?
|
| Vasa Vasorum | 1 | 1976 | 4 | 0.010 |
Why?
|
| Endothelium | 1 | 1976 | 59 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1977 | 173 | 0.010 |
Why?
|
| Epididymis | 2 | 1972 | 19 | 0.010 |
Why?
|
| Adenine | 2 | 1973 | 90 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 1976 | 121 | 0.010 |
Why?
|
| Mitosis | 1 | 1976 | 150 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 1969 | 383 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1975 | 16 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 1975 | 82 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1996 | 126 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1972 | 58 | 0.010 |
Why?
|
| Tolbutamide | 1 | 1975 | 16 | 0.010 |
Why?
|
| Liposomes | 2 | 1973 | 98 | 0.010 |
Why?
|
| Dialysis | 1 | 1974 | 23 | 0.010 |
Why?
|
| Calcinosis | 1 | 1976 | 222 | 0.010 |
Why?
|
| Blood Proteins | 2 | 1972 | 145 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1977 | 315 | 0.010 |
Why?
|
| Collagen | 1 | 1976 | 304 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1984 | 664 | 0.010 |
Why?
|
| Ischemia | 1 | 1976 | 253 | 0.010 |
Why?
|
| Hypoxia | 2 | 1969 | 675 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1973 | 40 | 0.010 |
Why?
|
| Apolipoprotein C-I | 1 | 1993 | 2 | 0.010 |
Why?
|
| 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase | 1 | 1993 | 2 | 0.010 |
Why?
|
| Chromosomes, Fungal | 1 | 1993 | 15 | 0.010 |
Why?
|
| Keto Acids | 1 | 1993 | 5 | 0.010 |
Why?
|
| Thymidine | 1 | 1973 | 59 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1973 | 46 | 0.010 |
Why?
|
| Glycerol | 1 | 1973 | 34 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1993 | 52 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 103 | 0.010 |
Why?
|
| Fats | 1 | 1972 | 12 | 0.010 |
Why?
|
| Ribosomes | 2 | 1972 | 102 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1974 | 419 | 0.010 |
Why?
|
| Genetic Code | 1 | 1972 | 24 | 0.010 |
Why?
|
| Chromosomes | 1 | 1972 | 91 | 0.010 |
Why?
|
| Proinsulin | 1 | 1972 | 123 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 1972 | 101 | 0.010 |
Why?
|
| Pancreatic Hormones | 1 | 1991 | 16 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1972 | 232 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1971 | 68 | 0.010 |
Why?
|
| Proteins | 2 | 1982 | 803 | 0.010 |
Why?
|
| C-Peptide | 1 | 1991 | 184 | 0.010 |
Why?
|
| Leukocytes | 1 | 1972 | 210 | 0.010 |
Why?
|
| Leucine | 3 | 1977 | 56 | 0.000 |
Why?
|
| Chloroplasts | 1 | 1970 | 61 | 0.000 |
Why?
|
| Lyases | 1 | 1969 | 11 | 0.000 |
Why?
|
| Menopause | 1 | 1990 | 87 | 0.000 |
Why?
|
| Protoplasts | 1 | 1969 | 4 | 0.000 |
Why?
|
| Ligases | 1 | 1969 | 44 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1971 | 522 | 0.000 |
Why?
|
| Cell Wall | 1 | 1970 | 71 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1997 | 4560 | 0.000 |
Why?
|
| Plasmalogens | 1 | 1968 | 2 | 0.000 |
Why?
|
| Biopsy | 1 | 1991 | 1175 | 0.000 |
Why?
|
| Sheep | 1 | 1968 | 203 | 0.000 |
Why?
|
| Aged | 2 | 1996 | 20434 | 0.000 |
Why?
|
| Bacteria | 1 | 1970 | 509 | 0.000 |
Why?
|
| Amino Acyl-tRNA Synthetases | 2 | 1974 | 15 | 0.000 |
Why?
|
| Inositol | 1 | 1984 | 17 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1984 | 99 | 0.000 |
Why?
|
| Homozygote | 1 | 1984 | 207 | 0.000 |
Why?
|
| Crosses, Genetic | 1 | 1984 | 165 | 0.000 |
Why?
|
| Phosphates | 1 | 1984 | 165 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1997 | 10164 | 0.000 |
Why?
|
| Glycolysis | 1 | 1984 | 187 | 0.000 |
Why?
|
| Pronase | 1 | 1982 | 5 | 0.000 |
Why?
|
| Iodine Isotopes | 2 | 1972 | 18 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1981 | 40 | 0.000 |
Why?
|
| NAD | 2 | 1972 | 97 | 0.000 |
Why?
|
| Chemistry | 1 | 1980 | 49 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1980 | 68 | 0.000 |
Why?
|
| Sterols | 1 | 1980 | 19 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1981 | 515 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1982 | 1133 | 0.000 |
Why?
|
| Galactosidases | 1 | 1977 | 13 | 0.000 |
Why?
|
| Kidney Cortex | 1 | 1977 | 30 | 0.000 |
Why?
|
| Deoxyribonucleases | 1 | 1977 | 27 | 0.000 |
Why?
|
| Glucuronidase | 1 | 1977 | 24 | 0.000 |
Why?
|
| Alkaline Phosphatase | 1 | 1977 | 128 | 0.000 |
Why?
|
| Erythromycin | 1 | 1974 | 10 | 0.000 |
Why?
|
| Chromatography | 1 | 1974 | 26 | 0.000 |
Why?
|
| Butter | 1 | 1974 | 2 | 0.000 |
Why?
|
| Oils | 1 | 1974 | 7 | 0.000 |
Why?
|
| Drug Stability | 1 | 1974 | 48 | 0.000 |
Why?
|
| Drug Resistance, Microbial | 1 | 1974 | 62 | 0.000 |
Why?
|
| Aspartic Acid | 1 | 1974 | 66 | 0.000 |
Why?
|
| Arachis | 1 | 1974 | 13 | 0.000 |
Why?
|
| Glutamates | 1 | 1974 | 84 | 0.000 |
Why?
|
| Silicon Dioxide | 1 | 1974 | 39 | 0.000 |
Why?
|
| Zea mays | 1 | 1974 | 27 | 0.000 |
Why?
|
| Tyrosine | 1 | 1974 | 131 | 0.000 |
Why?
|
| Autopsy | 1 | 1974 | 126 | 0.000 |
Why?
|
| Cytosol | 1 | 1974 | 193 | 0.000 |
Why?
|
| Serine | 1 | 1974 | 105 | 0.000 |
Why?
|
| Histidine | 1 | 1974 | 70 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1973 | 14 | 0.000 |
Why?
|
| Glucosamine | 1 | 1973 | 10 | 0.000 |
Why?
|
| Mannose | 1 | 1973 | 9 | 0.000 |
Why?
|
| Neuraminic Acids | 1 | 1973 | 11 | 0.000 |
Why?
|
| Urea | 1 | 1973 | 53 | 0.000 |
Why?
|
| Genes, Lethal | 1 | 1973 | 50 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1974 | 178 | 0.000 |
Why?
|
| Half-Life | 1 | 1972 | 93 | 0.000 |
Why?
|
| Citric Acid Cycle | 1 | 1972 | 28 | 0.000 |
Why?
|
| Electron Transport | 1 | 1972 | 72 | 0.000 |
Why?
|
| Immunoassay | 1 | 1972 | 99 | 0.000 |
Why?
|
| Electrophoresis | 1 | 1971 | 47 | 0.000 |
Why?
|
| Benzoates | 1 | 1971 | 33 | 0.000 |
Why?
|
| Genetics, Medical | 1 | 1972 | 51 | 0.000 |
Why?
|
| Blood Platelets | 1 | 1972 | 150 | 0.000 |
Why?
|
| Lactates | 1 | 1971 | 36 | 0.000 |
Why?
|
| Haploidy | 1 | 1971 | 30 | 0.000 |
Why?
|
| Duodenum | 1 | 1971 | 110 | 0.000 |
Why?
|
| Succinate Dehydrogenase | 1 | 1971 | 17 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1971 | 125 | 0.000 |
Why?
|
| Ileum | 1 | 1971 | 167 | 0.000 |
Why?
|
| Oxidoreductases | 1 | 1971 | 111 | 0.000 |
Why?
|
| Carbon | 1 | 1971 | 96 | 0.000 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1969 | 9 | 0.000 |
Why?
|
| Digitalis Glycosides | 1 | 1969 | 1 | 0.000 |
Why?
|
| Levulinic Acids | 1 | 1969 | 2 | 0.000 |
Why?
|
| Centrifugation | 1 | 1969 | 19 | 0.000 |
Why?
|
| Microsomes, Liver | 1 | 1969 | 48 | 0.000 |
Why?
|
| NADP | 1 | 1969 | 48 | 0.000 |
Why?
|
| Heme | 1 | 1969 | 64 | 0.000 |
Why?
|
| Leukemia | 1 | 1972 | 301 | 0.000 |
Why?
|
| Mitochondria, Muscle | 1 | 1969 | 25 | 0.000 |
Why?
|
| Lung | 1 | 1971 | 1366 | 0.000 |
Why?
|